- Home
- ELMD vs GALT Comparison
ELMD vs GALT Comparison
Compare ELMD & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- GALT
- Stock Information
- Founded
- ELMD 1992
- GALT 2000
- Country
- ELMD United States
- GALT United States
- Employees
- ELMD N/A
- GALT N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- GALT Health Care
- Exchange
- ELMD Nasdaq
- GALT Nasdaq
- Market Cap
- ELMD 172.2M
- GALT 83.5M
- IPO Year
- ELMD 2010
- GALT N/A
- Fundamental
- Price
- ELMD $20.78
- GALT $2.18
- Analyst Decision
- ELMD Strong Buy
- GALT Buy
- Analyst Count
- ELMD 1
- GALT 2
- Target Price
- ELMD $38.00
- GALT $6.00
- AVG Volume (30 Days)
- ELMD 115.0K
- GALT 1.4M
- Earning Date
- ELMD 08-26-2025
- GALT 08-12-2025
- Dividend Yield
- ELMD N/A
- GALT N/A
- EPS Growth
- ELMD 60.99
- GALT N/A
- EPS
- ELMD 0.79
- GALT N/A
- Revenue
- ELMD $61,439,000.00
- GALT N/A
- Revenue This Year
- ELMD $17.91
- GALT N/A
- Revenue Next Year
- ELMD $11.70
- GALT N/A
- P/E Ratio
- ELMD $26.34
- GALT N/A
- Revenue Growth
- ELMD 14.85
- GALT N/A
- 52 Week Low
- ELMD $13.74
- GALT $0.73
- 52 Week High
- ELMD $35.56
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- ELMD 47.25
- GALT 56.30
- Support Level
- ELMD $20.00
- GALT $2.08
- Resistance Level
- ELMD $22.16
- GALT $2.66
- Average True Range (ATR)
- ELMD 0.82
- GALT 0.53
- MACD
- ELMD 0.06
- GALT -0.02
- Stochastic Oscillator
- ELMD 36.95
- GALT 33.07
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.